Tool: DupCheckTool: DupCheck

www.DupCheck.org is a web-based tool to screen for duplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.


Project FlyerProject Flyer


Click here to download 
the NEWMEDS project flyer! 


ConsortiumConsortium
consortium teaser

QuicklinksQuicklinks
Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms




  Members Area
Username:
Password:



EU
IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations

logo Novartis

Novartis Campus
Forum 1
4056
Basel
Switzerland

Novartis www.nibr.com



Participant's Lead


Cristina Lopez-Lopez Cristina Lopez-Lopez
Translational Medicine Expert, Neuroscience Discovery, Novartis Institutes for BioMedical Research 
E-Mail to Cristina Lopez-Lopez Contact  
 



Institute Presentation


Novartis will partner in WP03 proving its expertise in clinical trials and  supplementing with  the placebo arm  of a Novartis development trial of a new compound with a CIAS target to examine the comparability and validity of CogState against the MCCB “standard” .
Novartis will partner in WP05 providing expertise in neuroimaging biomarkers, specifically receptor occupancy molecular imaging. Novartis will also monitor the project for opportunities to contribute technologies and tools to later stages of the program as it evolves to meet the central aims of the WP.


15 Novartis Pharma AG